Product
G2-TR intraocular implant containing travoprost
1 clinical trial
3 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%Status: Active (not recruiting), Estimated PCD: 2022-04-05